Good evening :)
Place Order
Add to Watchlist

Alpa Laboratories Ltd

ALPA

Alpa Laboratories Ltd

ALPA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹232 cr, stock is ranked 2,359
High RiskStock is 3.78x as volatile as Nifty
111.641.23% (+1.36)
111.641.23% (+1.36)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹232 cr, stock is ranked 2,359
High RiskStock is 3.78x as volatile as Nifty
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹232 cr, stock is ranked 2,359
High RiskStock is 3.78x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
12.231.53
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.226.550.51%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Alpa Laboratories Limited is a pharmaceutical company. The Company operates in the drugs and chemicals segment.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 8.22%, vs industry avg of 9.03%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.04% to 0.03%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 75.43%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue58.7768.5967.7183.2988.88101.95123.05102.33123.63120.40
Raw Materialssubtract31.8635.7935.9347.3151.4260.6269.2453.6768.6894.93
Power & Fuel Costsubtract1.491.581.762.012.212.432.643.043.02
Employee Costsubtract7.208.6710.2612.0411.8211.7511.9312.1713.29
Selling & Administrative Expensessubtract6.566.096.328.218.807.568.297.078.65
Operating & Other expensessubtract-0.356.324.657.288.377.509.508.937.00
Depreciation/Amortizationsubtract0.832.783.073.123.161.231.661.331.952.21
Interest & Other Itemssubtract1.451.711.070.570.200.080.220.220.360.38
Taxes & Other Itemssubtract2.893.121.831.741.063.545.473.313.903.91
EPS3.251.201.340.480.873.446.705.987.989.02
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Alpa Laboratories Ltd13.831.53
Sun Pharmaceutical Industries Ltd45.326.470.75%
Cipla Ltd31.054.770.82%
Mankind Pharma Ltd57.2011.43

Price Comparison

Compare ALPA with any stock or ETF
Compare ALPA with any stock or ETF
ALPA
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding57.29%0.00%0.00%0.74%41.96%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.11%0.95%0.50%0.36%0.74%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

ALPA has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Spotlight
Alpa Laboratories Ltd leads gainers in 'B' group

Vaswani Industries Ltd, FCS Software Solutions Ltd, Meera Industries Ltd and Zee Media Corporation Ltd are among the other gainers in the BSE's 'B' group today, 27 September 2024.Alpa Laboratories Ltd spiked 15.89% to Rs 128 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 78903 shares were traded on the counter so far as against the average daily volumes of 49367 shares in the past one month. Vaswani Industries Ltd soared 12.94% to Rs 58.91. The stock was the second biggest gainer in 'B' group. On the BSE, 1.2 lakh shares were traded on the counter so far as against the average daily volumes of 45791 shares in the past one month. FCS Software Solutions Ltd surged 12.39% to Rs 3.81. The stock was the third biggest gainer in 'B' group. On the BSE, 80.6 lakh shares were traded on the counter so far as against the average daily volumes of 13.1 lakh shares in the past one month. Meera Industries Ltd added 10.00% to Rs 108.24. The stock was the fourth biggest gainer in 'B' group. On the BSE, 41696 shares were traded on the counter so far as against the average daily volumes of 49229 shares in the past one month. Zee Media Corporation Ltd gained 9.99% to Rs 20.7. The stock was the fifth biggest gainer in 'B' group. On the BSE, 86.23 lakh shares were traded on the counter so far as against the average daily volumes of 13.89 lakh shares in the past one month. Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Alpa Laboratories to conduct AGM

Alpa Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Alpa Laboratories consolidated net profit rises 68.32% in the June 2024 quarter

Net profit of Alpa Laboratories rose 68.32% to Rs 5.10 crore in the quarter ended June 2024 as against Rs 3.03 crore during the previous quarter ended June 2023. Sales declined 15.69% to Rs 21.44 crore in the quarter ended June 2024 as against Rs 25.43 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales21.4425.43 -16 OPM %2.47-4.48 - PBDT5.643.28 72 PBT5.103.00 70 NP5.103.03 68 Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Alpa Laboratories standalone net profit rises 68.98% in the June 2024 quarter

Net profit of Alpa Laboratories rose 68.98% to Rs 5.12 crore in the quarter ended June 2024 as against Rs 3.03 crore during the previous quarter ended June 2023. Sales declined 15.69% to Rs 21.44 crore in the quarter ended June 2024 as against Rs 25.43 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales21.4425.43 -16 OPM %2.47-4.48 - PBDT5.643.28 72 PBT5.103.00 70 NP5.123.03 69 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Alpa Laboratories to convene board meeting

Alpa Laboratories will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live

Alpa Laboratories Ltd leads losers in ‘B’ group

1 year agoBusiness Standard

Globalspace Technologies Ltd leads losers in ‘B’ group

2 years agoBusiness Standard

Alpa Laboratories Ltd leads gainers in ‘B’ group

2 years agoBusiness Standard

Kaya Ltd leads gainers in ‘B’ group

3 years agoBusiness Standard

Alpa Laboratories Ltd leads gainers in ‘B’ group

3 years agoBusiness Standard